关于开发mRNA脂质纳米粒子疫苗和分析小鼠免疫效率的协议

Neha Karekar1, Ashley Reid Cahn2, Judit Morla-Folch3

  • 1Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

STAR protocols
|May 25, 2024
PubMed
概括

这项研究详细介绍了一个创建mRNA载脂质纳米粒子 (LNP) 疫苗的协议. 它涵盖了mRNA设计,LNP封装以及评估疫苗有效性和小鼠免疫反应的方法.

相关概念视频